Consensus document of the Interventional Cardiology and Heart Rhythm Associations of the Spanish Society of Cardiology on the management of invasive cardiac procedure rooms during the COVID-19 coronavirus outbreak
aServicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Universidad de Barcelona, Barcelona, España
bServicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, Salamanca, España
cServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, España
dServicio de Cardiología, Hospital Central de Asturias, Oviedo, Asturias, España
eServicio de Cardiología, Complejo Asistencial Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España
fServicio de Cardiología, Hospital Clínico San Carlos de Madrid, Madrid, España
gServicio de Cardiología, Hospital Clínic i Provincial de Barcelona, IDIBASP, Universitat de Barcelona, Barcelona, España
hUnidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario de Salamanca, Salamanca, España
iServicio de Cardiología, Hospital Universitario la Paz, Madrid, España
◊The undersigned authors are affiliated to the following scientific bodies: Interventional Cardiology Association of the Spanish Society of Cardiology: R. Romaguera (spokesperson), I. Cruz-González (president elect), S. Ojeda (spokesperson) and R. Moreno (president). Heart Rhythm Association of the Spanish Society of Cardiology: J. Jiménez-Candil (president), D. Calvo (president elect), J. García Seara (spokesperson), V. Cañadas-Godoy (spokesperson). Working Group on Interventional Cardiology of the Spanish Cardiovascular Nursing Association: E. Calvo.
REC Interv Cardiol. 2020;2:106-111
Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak.
aServicio de Cardiología, Hospital Universitario de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Universidad de Barcelona, Barcelona, Spain
bServicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
cServicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain
dServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain
eServicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain
fServicio de Cardiología, Complejo Hospitalario Universitario de Canarias, Tenerife, Santa Cruz de Tenerife, Spain
gServicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
1R. Romaguera, I. Cruz-González, and A. Jurado-Román contributed equally to this work as lead authors.
The undersigned authors are affiliated to the following scientific bodies: Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology: R. Romaguera (chair), I. Cruz-González (president-elect), S. Ojeda (chair), and R. Moreno (president). Spanish Society of Cardiology Working Group on Ischemic Heart Disease and Acute Cardiovascular Care: E. López-de-Sá (president), A. Ariza-Solé (president-elect), P. Jorge-Pérez (chair), and V. Burgos-Palacios (chair).◊
REC Interv Cardiol. 2020;2:112-117
Quantitative flow ratio in myocardial infarction for the evaluation of non-infarct-related arteries. The QIMERA pilot study
aDepartamento de Cardiología, Hospital Clínico Universitario, Valladolid, España
bServicio de Cardiología, Instituto de Ciencias del Corazón, ICICORELAB, Hospital Clínico Universitario, Valladolid, España
cDepartamento de Cardiología, Hospital Clínico Universitario, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Valladolid, España
dDepartamento de Cardiología, Hospital Punta de Europa, Algeciras, Cádiz, España
REC Interv Cardiol. 2019;1:13-20
Evolut R implantation in Perceval bioprosthesis with periprosthetic leakage. How would I approach it?
aServicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
bDepartamento de Medicina, Universidad de Oviedo, Oviedo, Asturias, España
cInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, España
REC Interv Cardiol. 2019;1:58-59
Impact of the COVID-19 pandemic on interventional cardiology activity in Spain
aInstitut del Cor, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
bInstitut per la Recerca Germans Trias i Pujol, Badalona, Barcelona, Spain
cCIBERCV, Instituto de Salud Carlos III, Madrid, Spain
dDepartamento de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
eDepartamento de Cardiología, Hospital Reina Sofía, Córdoba, Spain
fDepartamento de Cardiología, Hospital Clínico de Salamanca, Salamanca, Spain
gDepartamento de Cardiología, Hospital de Galdakao, Galdakao, Vizcaya, Spain
hDepartamento de Cardiología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain
iDepartamento de Cardiología, Hospital Clínico de Valladolid, Valladolid, Spain
jDepartamento de Cardiología, Hospital de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
kDepartamento de Cardiología, Hospital de León, León, Spain
lDepartamento de Cardiología, Hospital de La Paz, Madrid, Spain
◊ Annex 1 shows the participant centers and researchers in charge of each particular center.
REC Interv Cardiol. 2020;2:82-89
Aspirin-free antithrombotic management following coronary stenting. Myth or reality?
aDivision of Cardiology, CAST, P.O. “Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italia
bIcahn School of Medicine at Mount Sinai, New York, NY, Estados Unidos
cDivision of Cardiology, University of Florida College of Medicine, Jacksonville, FL, Estados Unidos
REC Interv Cardiol. 2019;1:62-66
The future of interventional cardiology
Emory University School of Medicine, Atlanta, Georgia, Estados Unidos
REC Interv Cardiol. 2019;1:4-5
Antithrombotic therapy after percutaneous revascularization in patients on chronic oral anticoagulation treatment
aServicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España
bÁrea de Enfermedades del Corazón, Hospital Universitario de Bellvitge – IDIBELL, Universidad de Barcelona, L’Hospitalet de Llobregat, Barcelona, España
REC Interv Cardiol. 2019;1:41-50
A newborn journal of interventional cardiology. Where are we going? A dialogue between generations
aDepartment of Cardiology, Academic Medical Center, University of Amsterdam, Ámsterdam, Países Bajos
bDepartment of Internal Medicine, Cardiology Division, University of Campinas (UNICAMP), Campinas, São Paulo, Brasil
cDepartment of Cardiology, Imperial College of London, Londres, Reino Unido
REC Interv Cardiol. 2019;1:6-10